Organ-on-chip technology refers to miniaturized systems designed to replicate the structure and function of human organs. These chips consist of microfluidic channels lined with living cells, allowing for the simulation of organ-specific functions and responses.
Traditional drug testing methods using animal models or cell cultures often fail to accurately predict human responses due to species differences and lack of complex tissue interactions. Organ-on-chip technology provides a more accurate model that can better mimic human physiology, improving the reliability of drug development processes.
The technology involves fabricating small-scale devices that mimic the complex architecture and physiological processes of real organs. Living cells are cultured within these microchannels to create a functional miniature organ. Fluids can be introduced into the channels to simulate blood flow, allowing for the study of organ function under various conditions.
Manufacturing organ-on-chip devices requires specialized microfabrication techniques such as photolithography and soft lithography. The process involves creating microchannels, embedding them with specific cell types, and integrating them into a larger system for fluidic control.
The build process typically includes designing the chip layout, fabricating the microfluidic channels using materials like PDMS (Polydimethylsiloxane), patterning the surface to support cell growth, and seeding cells into the channels. Fluidic systems are then integrated to allow for controlled fluid flow.
Curated names only — none are invented. Use the link to find more.
Cost drivers only — no verified dollar figures are shown. Check live sources for prices.
Illustrative — search real, dated examples rather than trusting a generated story.
Live searches — we don't list papers we can't verify.
Live patent searches — filings are never listed from memory.
Verify against primary sources only.
Source: curated technology intelligence stream with tracked references.